Toshiba America Medical Systems has received U.S. Food and Drug Administration (FDA) clearance for version 3.1 of its VirtualExplorer MR workstation software.
The new release features enhanced postprocessing functionality and a new cardiac package, according to the vendor. New features include 3D image visualization, a DICOM viewer, 2D filming, and the company's double oblique and virtual endoscope technology.
A cardiac edition of the software adds Toshiba's MR flow analysis, MR cardiac analysis, MR coronary analysis, and delayed enhancement tools, according to the vendor. Toshiba has also incorporated brain perfusion functionality into the neuro edition of the package.
